Telemedicine service. In addition to mental health and medical self-tests, the company has launched a sister brand, Spring, which serves as a grey market for ED pills (ones that would normally require a doctors prescription) at gospring.de, and hair loss at myspring.com, which, of course, the firm claims is “the most effective treatment in the world.”
Wellster has raised €61M across 3 funding rounds from 5 investors, most recently a round in Mar 2026. Based in Munich, Germany; active in Healthtech. Data as of 7 Aug 2026.
Timing: too soon vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.
| Date | Stage | Amount | Investors |
|---|
| 2026-03-23 | Other | €10M | Claret Capital Partners | View deal → |
| 2022-01-18 | Series B | €18M | Claret Capital Partners,Dermapharm,HV Capital,Mangrove Capital Partners,SevenVentures | View deal → |
| 2021-06-21 | Other | €34M | Dermapharm,HV Capital,SevenVentures | View deal → |
